Lisofylline

DB12406InvestigationalSmall molecule

Lisofylline has been investigated for the treatment of Type 1 Diabetes Mellitus.

Mechanism: Pharmacologically active on 1-acyl-sn-glycerol-3-phosphate acyltransferase beta
Curator reviewed
Formula / weight: C₁₃H₂₀N₄O₃ · 280.328 g/mol (avg)
Code names: CT 1501R

Resolves to

Compound

Structure

InChIKeyNSMXQKNUPPXBRG-SECBINFHSA-NSMILESC[C@@H](O)CCCCN1C(=O)N(C)C2=C(N(C)C=N2)C1=O

Targets

What you can answer from here — as of July 07, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

607Drug interactionsStructured to mechanism, not free text

3Clinical trialsPhase, status and sponsor resolved per trial

12+ReferencesStructured and connected to the statements they support

Which drugs share a target with Lisofylline, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.